Vanguard Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Vanguard Asset Management's BMY Position: Q2 2026 in Review
Vanguard Asset Management increased its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, buying an estimated $29.8M and bringing the position to 4,619,950 shares worth $266M. The position accounts for 0.18% of the portfolio, ranked #96.
Vanguard Asset Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,530 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Vanguard Asset Management held 4,619,950 shares of Bristol-Myers Squibb worth $266M as of Q2 2026.
- Vanguard Asset Management bought 518,605 Bristol-Myers Squibb shares in Q2 2026, an estimated $29.8M.
- Bristol-Myers Squibb made up 0.18% of Vanguard Asset Management's portfolio in Q2 2026, its #96 holding.
- Vanguard Asset Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- 2,530 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.